about
Antiviral therapy leads to histological improvement of HBeAg-negative chronic hepatitis B patients.Evaluation of Liver Fibrosis Using Texture Analysis on Combined-Contrast-Enhanced Magnetic Resonance Images at 3.0T.Liver fibrosis: possible involvement of EMT.Evaluation and management of patients with refractory ascites.Etiology and complications of liver cirrhosis in children:report of a single center from southern iran.Medical management of ascites.Beyond "cirrhosis": a proposal from the International Liver Pathology Study Group.Review article: the reversibility of cirrhosis.When to stop nucleos(t)ide analogues treatment for chronic hepatitis B? Durability of antiviral response.Fibroscan for assessing liver fibrosis: An acceptable alternative for liver biopsy: Fibroscan: an acceptable alternative for liver biopsy.Cell-based regenerative therapy as an alternative to liver transplantation for end-stage liver disease: experience from iran.Therapeutic effect of interleukin-10 on CCl4-induced hepatic fibrosis in rats.Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.Reversibility of experimental rabbit liver cirrhosis by portal collagenase administration.Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis.Improving Quality of Care in Patients with Liver Cirrhosis.Combined effects of an antioxidant and caspase inhibitor on the reversal of hepatic fibrosis in rats.
P2860
Q35779487-A76850CB-AEBE-45BB-935C-B9BF6621C0E4Q36059493-3A2D1A45-C582-4F0A-BEE4-C3E44392347EQ36857873-181E4902-EA1E-471A-B61C-D7B71E507BAFQ37122130-1948D4B7-37E1-4698-902A-9DE66F7CA6A2Q37708319-B1C2FFC3-7670-447B-BECE-650BCE886E26Q37838441-FDF67870-DC99-466C-B7D4-101FD5D64A71Q37969722-6CB61890-F89B-43A4-9D96-7A42F821D6D8Q38042443-5DEB385C-CBAF-4A7E-BEE9-1AB02E2CAB55Q38223364-67EF1046-EAB0-46D3-9126-FFE3E699E290Q38915082-9CAB5516-9B79-4571-8682-3E879EF302E1Q39913687-FB410514-2DC9-48AB-B6EF-76E7A4BDC88FQ42774193-A26F8AF0-0F6D-45E2-BA39-10FC40A1EFACQ42947269-116C611D-A77B-488B-82D7-21FCD79BE976Q46555492-4E43FDCA-FA3D-42F4-896E-4AA98B335143Q46700815-DF868A83-94CF-4C70-87CA-B149E85179B1Q47141166-37B5FE30-5FB4-4F25-8338-18B6EB5CF67BQ53315561-9A6B0A5D-9928-45BE-AC7E-6B0FBCEDDAC3
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Reversibility of cirrhosis in chronic hepatitis B.
@en
Reversibility of cirrhosis in chronic hepatitis B.
@nl
type
label
Reversibility of cirrhosis in chronic hepatitis B.
@en
Reversibility of cirrhosis in chronic hepatitis B.
@nl
prefLabel
Reversibility of cirrhosis in chronic hepatitis B.
@en
Reversibility of cirrhosis in chronic hepatitis B.
@nl
P50
P1476
Reversibility of cirrhosis in chronic hepatitis B.
@en
P2093
Amir Ali Sohrabpour
Shahin Merat
P304
P356
10.1016/S1542-3565(04)00066-7
P407
P50
P577
2004-04-01T00:00:00Z